O-4 Trifluridine/tipiracil (TAS-102) with or without bevacizumab in patients with pretreated metastatic esophago-gastric adenocarcinoma (mEGA): A Danish randomized trial (LonGas)

P. Pfeiffer; M. Yilmaz; M. Nordsmark; S. Möller; I. Elle; M. Ladekarl; S. Winther; C. Qvortrup; L. Baeksgaard

doi:10.1016/j.annonc.2022.04.445

O-4 Trifluridine/tipiracil (TAS-102) with or without bevacizumab in patients with pretreated metastatic esophago-gastric adenocarcinoma (mEGA): A Danish randomized trial (LonGas)

P. Pfeiffer, M. Yilmaz, M. Nordsmark, S. Möller, I. Elle, M. Ladekarl, S. Winther, C. Qvortrup, L. Baeksgaard

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Annals of Oncology
Vol/bind	33
Udgave nummer	Suppl. 4
Sider (fra-til)	S380
ISSN	0923-7534
DOI	https://doi.org/10.1016/j.annonc.2022.04.445
Status	Udgivet - jun. 2022
Begivenhed	ESMO 24th World Congress on Gastrointestinal Cancer 2022 - CCIB - Centre de Convencions Internacional de Barcelona, Barcelona, Spanien Varighed: 29 jun. 2022 → 2 jul. 2022 https://www.esmo.org/meetings/past-meetings/esmo-world-congress-on-gastrointestinal-cancer-2022

Konference

Konference	ESMO 24th World Congress on Gastrointestinal Cancer 2022
Lokation	CCIB - Centre de Convencions Internacional de Barcelona
Land/Område	Spanien
By	Barcelona
Periode	29/06/2022 → 02/07/2022
Internetadresse	https://www.esmo.org/meetings/past-meetings/esmo-world-congress-on-gastrointestinal-cancer-2022

Bibliografisk note

Abstrakt No. O-4

Adgang til dokumentet

10.1016/j.annonc.2022.04.445

https://linkinghub.elsevier.com/retrieve/pii/S0923753422011358

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Citationsformater

Pfeiffer, P., Yilmaz, M., Nordsmark, M., Möller, S., Elle, I., Ladekarl, M., Winther, S., Qvortrup, C., & Baeksgaard, L. (2022). O-4 Trifluridine/tipiracil (TAS-102) with or without bevacizumab in patients with pretreated metastatic esophago-gastric adenocarcinoma (mEGA): A Danish randomized trial (LonGas). Annals of Oncology, 33(Suppl. 4), S380. https://doi.org/10.1016/j.annonc.2022.04.445

@article{0117ec2ac0714c65b294385bcdbcb0f6,

title = "O-4 Trifluridine/tipiracil (TAS-102) with or without bevacizumab in patients with pretreated metastatic esophago-gastric adenocarcinoma (mEGA): A Danish randomized trial (LonGas)",

author = "P. Pfeiffer and M. Yilmaz and M. Nordsmark and S. M{\"o}ller and I. Elle and M. Ladekarl and S. Winther and C. Qvortrup and L. Baeksgaard",

note = "Abstract No. O-4; ESMO 24th World Congress on Gastrointestinal Cancer 2022 ; Conference date: 29-06-2022 Through 02-07-2022",

year = "2022",

month = jun,

doi = "10.1016/j.annonc.2022.04.445",

language = "English",

volume = "33",

pages = "S380",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier",

number = "Suppl. 4",

url = "https://www.esmo.org/meetings/past-meetings/esmo-world-congress-on-gastrointestinal-cancer-2022",

}

Pfeiffer, P, Yilmaz, M, Nordsmark, M, Möller, S, Elle, I, Ladekarl, M, Winther, S, Qvortrup, C & Baeksgaard, L 2022, 'O-4 Trifluridine/tipiracil (TAS-102) with or without bevacizumab in patients with pretreated metastatic esophago-gastric adenocarcinoma (mEGA): A Danish randomized trial (LonGas)', Annals of Oncology, bind 33, nr. Suppl. 4, s. S380. https://doi.org/10.1016/j.annonc.2022.04.445

O-4 Trifluridine/tipiracil (TAS-102) with or without bevacizumab in patients with pretreated metastatic esophago-gastric adenocarcinoma (mEGA): A Danish randomized trial (LonGas). / Pfeiffer, P.; Yilmaz, M.; Nordsmark, M. et al.
I: Annals of Oncology, Bind 33, Nr. Suppl. 4, 06.2022, s. S380.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - O-4 Trifluridine/tipiracil (TAS-102) with or without bevacizumab in patients with pretreated metastatic esophago-gastric adenocarcinoma (mEGA): A Danish randomized trial (LonGas)

AU - Pfeiffer, P.

AU - Yilmaz, M.

AU - Nordsmark, M.

AU - Möller, S.

AU - Elle, I.

AU - Ladekarl, M.

AU - Winther, S.

AU - Qvortrup, C.

AU - Baeksgaard, L.

N1 - Abstract No. O-4

PY - 2022/6

Y1 - 2022/6

U2 - 10.1016/j.annonc.2022.04.445

DO - 10.1016/j.annonc.2022.04.445

M3 - Conference abstract in journal

SN - 0923-7534

VL - 33

SP - S380

JO - Annals of Oncology

JF - Annals of Oncology

IS - Suppl. 4

T2 - ESMO 24th World Congress on Gastrointestinal Cancer 2022

Y2 - 29 June 2022 through 2 July 2022

ER -